tiprankstipranks
Trending News
More News >
Purple Biotech (PPBT)
NASDAQ:PPBT
US Market

Purple Biotech (PPBT) Income Statement

Compare
1,096 Followers

Purple Biotech Income Statement

Last quarter (Q3 2025), Purple Biotech's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Purple Biotech's net income was $-1.31M. See Purple Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 195.80K$ 0.00$ 0.00$ 1.00M
Gross Profit
$ -186.00K$ -196.00$ -120.00$ -55.00$ 999.94K
Operating Expenses
$ 11.01M$ -22.47M$ 22.60M$ 17.93M$ 13.24M
Depreciation and Amortization
$ 186.00K$ 46.00K$ 201.00K$ 231.00K$ 235.00K
EBITDA
$ -7.05M$ -19.88M$ -21.49M$ -17.52M$ -28.41M
Operating Income
$ -11.01M$ -22.27M$ -22.60M$ -17.93M$ -13.24M
Other Income/Expenses
$ 3.73M$ 2.29M$ 843.00K$ 108.00K$ -15.46M
Pretax Income
$ -7.28M$ -19.98M$ -21.76M$ -17.83M$ -28.70M
Net Income
$ -7.24M$ -19.88K$ -21.67M$ -18.38M$ -28.00M
Per Share Metrics
Basic EPS
$ -4.42$ -0.16$ -0.23$ -0.21$ -0.35
Diluted EPS
$ -4.42$ -0.16$ -0.23$ -0.21$ -0.35
Weighted Average Shares Outstanding
2.59M 1.23M 924.08K 890.00K 860.53K
Weighted Average Shares Outstanding (Diluted)
2.59M 1.23M 924.08K 890.00K 860.53K
Currency in USD

Purple Biotech Earnings and Revenue History